BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7665142)

  • 1. Thymoma--a study of 60 cases in Singapore.
    Tan PH; Sng IT
    Histopathology; 1995 Jun; 26(6):509-18. PubMed ID: 7665142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymoma. Histologic subclassification is an independent prognostic factor.
    Quintanilla-Martinez L; Wilkins EW; Choi N; Efird J; Hug E; Harris NL
    Cancer; 1994 Jul; 74(2):606-17. PubMed ID: 8033040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoma--morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases.
    Quintanilla-Martinez L; Wilkins EW; Ferry JA; Harris NL
    Hum Pathol; 1993 Sep; 24(9):958-69. PubMed ID: 8253462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological study of thymomas--correlation of histologic subtype to myasthenia gravis and prognosis.
    Sundaram C; Rajagopal P; Rakshak AD; Omprakash G; Das SM; Murthy JM
    Indian J Pathol Microbiol; 2003 Jul; 46(3):378-81. PubMed ID: 15025278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a histogenetic classification for thymic epithelial tumours.
    Ho FC; Fu KH; Lam SY; Chiu SW; Chan AC; Müller-Hermelink HK
    Histopathology; 1994 Jul; 25(1):21-9. PubMed ID: 7959642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymoma: a study of the pathologic classification of 71 cases with evaluation of the Muller-Hermelink system.
    Kuo TT; Lo SK
    Hum Pathol; 1993 Jul; 24(7):766-71. PubMed ID: 8319955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant grading of cortical and medullary differentiated thymoma by morphometric analysis.
    Nomori H; Ishihara T; Torikata C
    Cancer; 1989 Oct; 64(8):1694-9. PubMed ID: 2676138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphometrical and immunohistochemical analysis of cortical and medullary thymoma: its correlation with invasiveness and association with myasthenia gravis].
    Nomori H; Ishihara T; Torikata C
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Jan; 38(1):93-100. PubMed ID: 1691772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-ploidy analysis correlates with the histogenetic classification of thymic epithelial tumours.
    Gschwendtner A; Fend F; Hoffmann Y; Krugmann J; Klingler PJ; Mairinger T
    J Pathol; 1999 Dec; 189(4):576-80. PubMed ID: 10629561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymomas and thymic carcinomas. Evaluation of the Müller-Hermelink classification.
    Papla B; Rudnicka L; Dubiel-Bigaj M; Malinowski E
    Pol J Pathol; 1998; 49(4):251-65. PubMed ID: 10323079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus.
    Marino M; Müller-Hermelink HK
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(2):119-49. PubMed ID: 3927579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive medullary thymoma associated with Myasthenia gravis: an unusual case.
    Reis Filho JS; Milanezi MF; Moreira CG; Werneck LC; Boscardin P; Ioshii SO; Schmitt FC
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1110-4. PubMed ID: 11105080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies regarding the pathology of thymomas.
    Kornstein MJ
    Pathol Annu; 1992; 27 Pt 2():1-15. PubMed ID: 1584624
    [No Abstract]   [Full Text] [Related]  

  • 14. Thymoma: a pathological study of 50 cases.
    Vaideeswar P; Padmanabhan A; Deshpande JR; Pandit SP
    J Postgrad Med; 2004; 50(2):94-7. PubMed ID: 15235201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of CD20 in thymomas and its clinical implication].
    Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Müller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification.
    Hattori H; Tateyama H; Tada T; Saito Y; Yamakawa Y; Eimoto T
    Virchows Arch; 2000 Jan; 436(1):20-7. PubMed ID: 10664158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoma: a clinico-pathologic study based on newly developed morphologic criteria.
    Rendina EA; Pescarmona EO; Venuta F; Nardi S; De Rosa G; Martelli M; Ricci C
    Tumori; 1988 Feb; 74(1):79-84. PubMed ID: 3354066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic importance of histomorphologic subclassification for epithelial thymic tumors.
    Schneider PM; Fellbaum C; Fink U; Bollschweiler E; Präuer HW
    Ann Surg Oncol; 1997 Jan; 4(1):46-56. PubMed ID: 8985517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological aspects of malignant and benign thymic disorders.
    Müller-Hermelink HK; Marx A
    Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathological correlation of epithelial subtyping in thymoma: a study of 112 consecutive cases.
    Pan CC; Wu HP; Yang CF; Chen WY; Chiang H
    Hum Pathol; 1994 Sep; 25(9):893-9. PubMed ID: 8088764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.